Publication ethics

Biolife is committed to upholding the integrity of all its publications. It is necessary

therefore to agree on the standards of ethical behavior expected from all parties involved

in the publishing process; these include the author, the editor, the peer reviewer and the

publisher. Biolife follows the COPE Best Practice Guidelines on publishing ethics. Full

details of these guidelines can be found on the COPE website.

 

Biolife does not tolerate plagiarism, or the publication of material that is libelous, illegal or

which infringes the copyright or other rights of any third party. In addition, the manipulation

of scientific data, tables, figures or any text for the purpose of knowingly providing incorrect

information in order to manipulate the process of peer review is strictly prohibited.

Authors publishing a paper with Biolife should certify that (i) all those mentioned in the list

of authors have contributed significantly to the paper, (ii) no person who has made a

significant contribution has been omitted from the list of authors or acknowledged persons,

(iii) all sources of external funding have been revealed in the acknowledgments section,

(iv) the paper has not been and will not be submitted to any other publication until either

the review process has been completed or the paper has been withdrawn, (v) the

submitting author assumes responsibility, within the limits of his or her professional

competence, for the accuracy of the paper, and (vi) the authors have read and agree to

the Biolife copyright agreement.

 

The editor or peer reviewer of any Biolife publication shall evaluate manuscripts on their

intellectual content, irrespective of the race, gender, sexual orientation, religious belief,

ethnic origin, citizenship, or political philosophy of the authors. The editor and any editorial

staff shall not disclose any confidential information concerning a submitted manuscript to

anyone other than the corresponding author, reviewers, potential reviewers, other editorial

advisers, or publisher, as appropriate. The content of any unpublished materials disclosed

in a submitted manuscript is not to be used, either in whole or in part, in an editor’s own

research without the express written consent of the submitting author.

 

The publisher, Biolife, affirms that any misconduct, in the form of fabrication, falsification or

plagiarism, jeopardizes the success of the entire scientific endeavor. Any questions raised

with regard to possible misconduct or plagiarism will initially be evaluated by the editor(s)

of the publication, in consultation with the manuscript’s peer reviewer(s) if appropriate. If

deemed appropriate, the matter will be taken up with the institution where the scientific

work in question was performed. In principle, matters will be reviewed in accordance with

the institutional procedures for handling allegations of misconduct. At all stages, every

effort should be made to ensure that the process is fair and just, both for those who have

been accused of misconduct and for those who have raised the issue of scientific

misconduct. In the event that a published article must be retracted or corrected, a

statement of retraction or correction, usually in the form of an erratum, will be published.

Articles may be removed from the publication if deemed appropriate.

 

Biolife expects authors to abide by the general ethics polices outlined by The Council of

Scientific Editors and COPE. Please use the links below as references.

 

COUNCIL OF SCIENTIFIC EDITORS

 

CSE’s White Paper on Promoting Integrity in Scientific Journal Publications:

http://www.councilscienceeditors.org/i4a/pages/index.cfm?pageid=3331

 

Download a PDF of the entire White Paper

 

 

COPE

Responsible research publication: International standards for authors:

http://www.publicationethics.org/files/International%20standards_authors_for%20website_

11_Nov_2011.pdf

 

Print Friendly, PDF & Email